Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-24

Clinical Trial Update: Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity

View source ↗

Summary

This clinical trial update describes evaluating CXCL5 levels in patients with systemic lupus erythematosus and how they relate to disease activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: SLE (Systemic Lupus) | Status: NOT_YET_RECRUITING